<SEC-DOCUMENT>0001178913-26-002070-index.html : 20260410
<SEC-HEADER>0001178913-26-002070.hdr.sgml : 20260410
<ACCEPTANCE-DATETIME>20260410161500
ACCESSION NUMBER:		0001178913-26-002070
CONFORMED SUBMISSION TYPE:	3
PUBLIC DOCUMENT COUNT:		1
CONFORMED PERIOD OF REPORT:	20260318
FILED AS OF DATE:		20260410
DATE AS OF CHANGE:		20260410

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			Mor George Adi
		CENTRAL INDEX KEY:			0001851069
		ORGANIZATION NAME:           	

	FILING VALUES:
		FORM TYPE:		3
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-38807
		FILM NUMBER:		26855031

	MAIL ADDRESS:	
		STREET 1:		15 KAFRISIN ST.
		CITY:			TEL AVIV
		STATE:			L3
		ZIP:			6901658

ISSUER:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Chemomab Therapeutics Ltd.
		CENTRAL INDEX KEY:			0001534248
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		EIN:				813676773
		STATE OF INCORPORATION:			L3
		FISCAL YEAR END:			1231

	BUSINESS ADDRESS:	
		ADDRESS IS A NON US LOCATION: 	YES
		STREET 1:		KIRYAT ATIDIM, BUILDING 7
		CITY:			TEL AVIV
		PROVINCE COUNTRY:   	L3
		BUSINESS PHONE:		972-77-331-0156

	MAIL ADDRESS:	
		ADDRESS IS A NON US LOCATION: 	YES
		STREET 1:		KIRYAT ATIDIM, BUILDING 7
		CITY:			TEL AVIV
		PROVINCE COUNTRY:   	L3

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Anchiano Therapeutics Ltd.
		DATE OF NAME CHANGE:	20180906

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	BioCancell Ltd.
		DATE OF NAME CHANGE:	20111104
</SEC-HEADER>
<DOCUMENT>
<TYPE>3
<SEQUENCE>1
<FILENAME>zk2635059.xml
<TEXT>
Document 1 - file: zk2635059.html

Document 1 - RAW XML: zk2635059.xml

</DOCUMENT>
</SEC-DOCUMENT>